
Unitree builds AI-powered robots that rival Tesla's Optimus units. Unitree raised more than $900 million with its IPO.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Unitree builds AI-powered robots that rival Tesla's Optimus units. Unitree raised more than $900 million with its IPO.

The company's struggling shares are launching back into orbit.

A Plexo Capital partner who owns Anthropic shares went on CNBC to defend a valuation that dwarfs every profitable public AI company, and the caveat he buried in his own argument may be the most important thing he said.

Kailera Therapeutics raised one of the biggest obesity biotech IPOs in recent memory, then watched its stock drop nearly 30%. Now several of the world's largest drugmakers have a compelling reason to make a move before pivotal trial data arrives.

Ackman put new capital to work in the second quarter of the year.
FORT Robotics plans to go public through a business combination with Newbury Street II Acquisition (

A top market strategist just called out the biggest risk hiding inside Anthropic's upcoming IPO, and it has nothing to do with the quality of the company or its technology.

This company's human-powered platform bucks the artificial intelligence (AI) trend.

Nvidia stock touched $227 a share Monday on news it's pouring $1.5 billion into this AI data center and energy player.

Companies try to get deals done while regulators allow them. But are buyouts always a good idea?

For investors who want to bet on a future rebound in the U.S. housing market, this homebuilder ETF could be a good buy today.

Oklo had a disastrous market debut. Investors who held on to their shares, however, have had the last laugh.

Even after its recent rally, there could be more meaningful gains ahead for SpaceX.

There's a good reason why AstraZeneca tanked when merger rumors hit the Street.

OpenAI's IPO target is colliding with SoftBank's 2027 deadline.

Investors believe Anthropic could target an IPO valuation north of $2 trillion, according to the Financial Times.

A Chinese humanoid robotics IPO just shattered demand records, and the shockwave is already hitting a handful of niche ETFs built exactly for this moment. Whether that momentum holds depends on two wildcards most investors are not watching closely enough.
Chipotle shares have cratered more than 26% below where analysts think they should be trading, yet nearly every Wall Street voice covering the stock refuses to walk away. Whether that conviction holds up against mounting cost pressures and a skittish consumer is the real question.
With shares now trading at a steep discount, is this a generational buying opportunity?
Strategic buyers are chasing scarce real-time AI technology
Initial public offerings won't unlock instant wealth for retail investors.
Sell-side analysts have parked on Hold while some of the sharpest event-driven hedge funds in the business are quietly building complex positions around Norfolk Southern's pending merger. The two camps are not fighting over fundamentals. They are betting on very different things entirely.
SpaceX has struggled in recent weeks.
The answer to who is funding the AI build-out could matter far more for cash-burning AI companies than for Nvidia itself.
The newly public companies offer investors a choice between the hot space sector and the emerging quantum computing market.
Wall Street Says AMD's Taalas Deal Won't Close Nvidia's AI Gap
Homegrown companies continue to struggle to access capital and move from research to commercialization
Brookfield (TSX:BN) has completed its acquisition of Oaktree, expanding its global credit management platform. The company has entered a multi billion dollar joint venture with Blackstone and KKR for Kuwait’s entire pipeline network. Brookfield has formed a partnership with NAVER and NVIDIA to build one of the world’s largest AI focused data center infrastructure platforms. Consider expanding your watchlist to other companies shaping AI infrastructure and related assets through 56 AI...
Humanoid robot developer Unitree announced it will price its upcoming IPO at $22.34 a share, giving it a valuation of $9 billion. The deal will make Unitree China's first public humanoid robot company. Unitree's IPO comes at a time when investors are becoming increasingly focused on the prospect of AI-enabled robotics.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.